Pfizer’s Paxlovid fails as 15-day treatment for long COVID, study finds
By Michael Erman (Reuters) – A 15-day course of Pfizer’s COVID-19 antiviral treatment Paxlovid did...
By Michael Erman (Reuters) – A 15-day course of Pfizer’s COVID-19 antiviral treatment Paxlovid did...
By Louise Rasmussen and Gwladys Fouche OSLO (Reuters) -Norway’s $1.7 trillion sovereign wealth fund said...
(Reuters) – The S&P Dow Jones Indices said on Friday that private equity firm KKR...
By David Randall and Noel Randewich (Reuters) – Stock influencer Keith Gill’s first livestream in...
(Reuters) -The U.S. health regulator on Friday advised COVID-19 vaccine manufacturers that new shots for...
LONDON (Reuters) – Global payments processors Visa and Mastercard must face a new set of...
By Maha El Dahan, Hadeel Al Sayegh and Yousef Saba DUBAI (Reuters) -Saudi Arabia is...
By Tom Hals WILMINGTON, Delaware (Reuters) – The legal team that voided Elon Musk’s record...
(Reuters) -Shares of Geron rose more than 16% on Friday before markets opened, a day...
ST PETERSBURG (Reuters) -President Vladimir Putin said on Friday Russia needed to cut imports, significantly...